170 related articles for article (PubMed ID: 30289582)
21. Molecular approaches for classifying endometrial carcinoma.
Piulats JM; Guerra E; Gil-Martín M; Roman-Canal B; Gatius S; Sanz-Pamplona R; Velasco A; Vidal A; Matias-Guiu X
Gynecol Oncol; 2017 Apr; 145(1):200-207. PubMed ID: 28040204
[TBL] [Abstract][Full Text] [Related]
22. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
23. Micro-histology combined with cytology improves the diagnostic accuracy of endometrial lesions.
Wang Y; Zhao L; Zhang K; Liu Y; Guo L; Jing W; Hou H; Shi G; Bin Y; Zhang S; Zhang G; Li Q
Cancer Med; 2023 Aug; 12(16):17028-17036. PubMed ID: 37458126
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y; Oda K; Nakagawa S; Murayama-Hosokawa S; Yamamoto S; Ishikawa S; Wang L; Takazawa Y; Maeda D; Wada-Hiraike O; Kawana K; Fukayama M; Aburatani H; Yano T; Kozuma S; Taketani Y
Int J Gynecol Cancer; 2012 Jun; 22(5):725-31. PubMed ID: 22635024
[TBL] [Abstract][Full Text] [Related]
26. Early-stage endometrial cancer, CTNNB1 mutations, and the relation between lymphovascular space invasion and recurrence.
Imboden S; Tapia C; Scheiwiller N; Kocbek V; Altermatt HJ; Janzen J; Mueller MD; McKinnon B
Acta Obstet Gynecol Scand; 2020 Feb; 99(2):196-203. PubMed ID: 31562818
[TBL] [Abstract][Full Text] [Related]
27. Direct next-generation sequencing analysis using endometrial liquid-based cytology specimens for rapid cancer genomic profiling.
Akahane T; Kitazono I; Kobayashi Y; Nishida-Kirita Y; Yamaguchi T; Yanazume S; Tabata K; Kobayashi H; Tanimoto A
Diagn Cytopathol; 2021 Sep; 49(9):1078-1085. PubMed ID: 34319014
[TBL] [Abstract][Full Text] [Related]
28. Application of immunocytochemical and molecular analysis of six genes in liquid-based endometrial cytology.
Munakata S; Yamamoto T
Diagn Cytopathol; 2022 Jan; 50(1):8-17. PubMed ID: 34783431
[TBL] [Abstract][Full Text] [Related]
29. Morphological Differences between Liquid-Based Cytology and Conventional Preparation in Endometrial Endometrioid Carcinoma Grade 1 and Grade 3, and the Differentiation of Grades in Each Method.
Odashima H; Yoshioka H; Ota K; Goto Y; Noro M; Horie K; Watanabe J
Acta Cytol; 2021; 65(3):227-234. PubMed ID: 33652432
[TBL] [Abstract][Full Text] [Related]
30. A Diagnostic Approach to Endometrial Cytology by Means of Liquid-Based Preparations.
Norimatsu Y; Yanoh K; Hirai Y; Kurokawa T; Kobayashi TK; Fulciniti F
Acta Cytol; 2020; 64(3):195-207. PubMed ID: 31473735
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
Reijnen C; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; van der Wurff AAM; Ligtenberg MJL; Massuger LFAG; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 May; 146(9):2628-2635. PubMed ID: 31523803
[TBL] [Abstract][Full Text] [Related]
32. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
33. Detection of oncogenic mutations in cervical carcinoma using method High Resolution Melting (HRM).
Wayhelova M; Mikulasova A; Smetana J; Vallova V; Blazkova D; Filkova H; Moukova L; Kuglik P
Neoplasma; 2016; 63(5):779-88. PubMed ID: 27468883
[TBL] [Abstract][Full Text] [Related]
34. Endometrial carcinoma in high-risk populations: is it time to consider a screening policy?
Fambrini M; Sorbi F; Sisti G; Cioni R; Turrini I; Taddei G; Guaschino S
Cytopathology; 2014 Apr; 25(2):71-7. PubMed ID: 24467297
[TBL] [Abstract][Full Text] [Related]
35. Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.
Kang S; Seo SS; Chang HJ; Yoo CW; Park SY; Dong SM
Int J Gynecol Cancer; 2008; 18(6):1339-43. PubMed ID: 18221484
[TBL] [Abstract][Full Text] [Related]
36. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Myers AP; Filiaci VL; Zhang Y; Pearl M; Behbakht K; Makker V; Hanjani P; Zweizig S; Burke JJ; Downey G; Leslie KK; Van Hummelen P; Birrer MJ; Fleming GF
Gynecol Oncol; 2016 Apr; 141(1):43-8. PubMed ID: 27016228
[TBL] [Abstract][Full Text] [Related]
37. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
[TBL] [Abstract][Full Text] [Related]
39. Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath
Norimatsu Y; Yamaguchi T; Taira T; Abe H; Sakamoto H; Takenaka M; Yanoh K; Yoshinobu M; Irino S; Hirai Y; Kobayashi TK
Cytopathology; 2016 Dec; 27(6):472-478. PubMed ID: 27109167
[TBL] [Abstract][Full Text] [Related]
40. The Role of Liquid Based Cytology and Ancillary Techniques in the Peritoneal Washing Analysis: Our Institutional Experience.
Rossi E; Bizzarro T; Martini M; Longatto-Filho A; Schmitt F; Fagotti A; Scambia G; Zannoni GF
PLoS One; 2017; 12(1):e0168625. PubMed ID: 28099523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]